The purpose of this study is characterize the dose-effect relationship of rocuronium bromide
at the adductor pollicis and masseter muscles using an pharmacokinetic-pharmacodynamic (PKPD)
model. The hypothesis is that masseter muscle has a greater sensitivity to the neuromuscular
blockers (rocuronium), faster onset and slower recovery profile than the adductor pollicis
muscle.